MedTrace Logo

Regulatory Post Marketing Surveillance Study on YAZ

NCT00998257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 770

Last updated 2015-01-21

No results posted yet for this study

Summary

The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.

Conditions

  • Contraception
  • Premenstrual Syndrome
  • Acne

Interventions

DRUG

EE20/DRSP (YAZ, BAY86-5300)

Patients under daily life treatment with YAZ according to local drug information.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • South Korea

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00998257 on ClinicalTrials.gov